首页 > 最新文献

Movement Disorders Clinical Practice最新文献

英文 中文
MR-Guided Focused Ultrasound for the Treatment of Tremor in Fragile X-Associated Tremor/Ataxia Syndrome. 磁共振引导聚焦超声治疗脆性 X 相关震颤/共济失调综合征的震颤。
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-21 DOI: 10.1002/mdc3.14270
Jesús García-de Soto, Jessica María Pouso-Diz, Gustavo Fernández-Pajarín, Paula Román-Pena, Amanda Álvarez-Noval, Miguel Blanco-Ulla, Eduardo Arán-Echabe, Begoña Ares, Ángel Sesar
{"title":"MR-Guided Focused Ultrasound for the Treatment of Tremor in Fragile X-Associated Tremor/Ataxia Syndrome.","authors":"Jesús García-de Soto, Jessica María Pouso-Diz, Gustavo Fernández-Pajarín, Paula Román-Pena, Amanda Álvarez-Noval, Miguel Blanco-Ulla, Eduardo Arán-Echabe, Begoña Ares, Ángel Sesar","doi":"10.1002/mdc3.14270","DOIUrl":"https://doi.org/10.1002/mdc3.14270","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Hemispheric Asymmetry of Dopamine-Transporter Binding with Risk of Parkinsonian Depression. 多巴胺-转运体结合的半球不对称与帕金森抑郁症风险的关系
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-20 DOI: 10.1002/mdc3.14276
Emilio Fernández-Espejo, Fernando Rodríguez de Fonseca

Background: Depression is the most common psychiatric disorder diagnosed in patients with Parkinson's disease (PD). A direct role in PD depression for loss of dopaminergic terminals and dopamine-transporter (DAT) expression in the striatum is revealed by many studies.

Objectives: The objective was to discern the relationship between DAT neuroimaging and risk of depression in PD.

Methods: One hundred and ninety-eight PD patients (101 with depression, 97 without depression) were evaluated using an extensive protocol from 2015 to 2023. DAT availability at striatal terminals was assessed with single-photon emission computed tomography with 123I-Ioflupane. Specific binding ratio (SBR) of 123I-Ioflupane and the whole striatum asymmetry index (SASI) were calculated. Data were analyzed with univariate/multivariate models as well as receiver operating characteristic (ROC) curves.

Results: A logistic regression model adjusting for confounding risk factors of depression indicates that SASI and PD duration are associated with the odds of having parkinsonian depression. SASI is the strongest predictor of risk of parkinsonian depression. Following ROC analysis, SASI is found to be an accurate factor for detecting parkinsonian depression because a cutoff value of 3.4895 of SASI shows good accuracy (0.813), sensitivity (81.1%), and specificity (80%). Higher SASI is also linked to more disease-related limitations in activities of daily living.

Conclusion: The whole SASI is the strongest predictor of risk of parkinsonian depression. The findings could be valuable in evaluating depression in PD patients.

背景:抑郁症是帕金森病(PD)患者中最常见的精神疾病。许多研究表明,纹状体中多巴胺能末梢和多巴胺转运体(DAT)表达的丧失在帕金森病抑郁症中起着直接作用:目的:研究DAT神经影像与帕金森病抑郁风险之间的关系:从2015年到2023年,采用广泛的方案对198名帕金森病患者(101名抑郁症患者,97名非抑郁症患者)进行了评估。用123I-Ioflupane单光子发射计算机断层扫描评估纹状体终端的DAT可用性。计算了 123I-Ioflupane 的特异性结合率 (SBR) 和整个纹状体不对称指数 (SASI)。数据采用单变量/多变量模型以及接收器操作特征曲线(ROC)进行分析:结果:调整了抑郁症混杂风险因素的逻辑回归模型表明,SASI和帕金森病持续时间与帕金森抑郁症的患病几率有关。SASI 是帕金森抑郁症风险的最强预测因子。根据 ROC 分析,SASI 是检测帕金森抑郁症的准确因素,因为 SASI 的临界值 3.4895 显示出良好的准确性(0.813)、敏感性(81.1%)和特异性(80%)。较高的 SASI 也与日常生活活动中更多与疾病相关的限制有关:结论:整体 SASI 是帕金森抑郁风险的最强预测指标。结论:整体 SASI 是预测帕金森抑郁风险的最有力指标,其研究结果对评估帕金森病患者的抑郁情况很有价值。
{"title":"Association of Hemispheric Asymmetry of Dopamine-Transporter Binding with Risk of Parkinsonian Depression.","authors":"Emilio Fernández-Espejo, Fernando Rodríguez de Fonseca","doi":"10.1002/mdc3.14276","DOIUrl":"https://doi.org/10.1002/mdc3.14276","url":null,"abstract":"<p><strong>Background: </strong>Depression is the most common psychiatric disorder diagnosed in patients with Parkinson's disease (PD). A direct role in PD depression for loss of dopaminergic terminals and dopamine-transporter (DAT) expression in the striatum is revealed by many studies.</p><p><strong>Objectives: </strong>The objective was to discern the relationship between DAT neuroimaging and risk of depression in PD.</p><p><strong>Methods: </strong>One hundred and ninety-eight PD patients (101 with depression, 97 without depression) were evaluated using an extensive protocol from 2015 to 2023. DAT availability at striatal terminals was assessed with single-photon emission computed tomography with <sup>123</sup>I-Ioflupane. Specific binding ratio (SBR) of <sup>123</sup>I-Ioflupane and the whole striatum asymmetry index (SASI) were calculated. Data were analyzed with univariate/multivariate models as well as receiver operating characteristic (ROC) curves.</p><p><strong>Results: </strong>A logistic regression model adjusting for confounding risk factors of depression indicates that SASI and PD duration are associated with the odds of having parkinsonian depression. SASI is the strongest predictor of risk of parkinsonian depression. Following ROC analysis, SASI is found to be an accurate factor for detecting parkinsonian depression because a cutoff value of 3.4895 of SASI shows good accuracy (0.813), sensitivity (81.1%), and specificity (80%). Higher SASI is also linked to more disease-related limitations in activities of daily living.</p><p><strong>Conclusion: </strong>The whole SASI is the strongest predictor of risk of parkinsonian depression. The findings could be valuable in evaluating depression in PD patients.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142676195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Perspectives on Upper-Limb Daily Function in Parkinson's Disease. 帕金森病患者对上肢日常功能的看法。
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-19 DOI: 10.1002/mdc3.14277
Noa Cohen, Rachel Kizony

Background: Dexterity impairments are common among people with Parkinson's disease (PWP), yet little is understood about the effect of upper-limb (UL) dysfunction on daily activity performance.

Objectives: The aims were to (1) map the dexterity activities most affected and meaningful to PWP; (2) explore the associations between perceived dexterity function and disease severity, cognitive and motor UL impairments, dexterity ability, self-reported activities of daily living (ADL) function, and quality of life (QOL); (3) investigate variables explaining perceived dexterity function; and (4) examine the differences in perceived dexterity function based on dominance affectedness.

Methods: A total of 43 PWP (mean age = 70.00 years, standard deviation [SD] = 6.75) were assessed for perceived dexterity function (36-item Dexterity Questionnaire [DextQ-36]), dexterity ability (Coin Rotation Task), disease severity (modified Hoen and Yahr Scale), self-reported ADL function and motor UL impairments (Movement Disorder Society-Unified Parkinson's Disease Rating Scale), cognition (Montreal Cognitive Assessment), and QOL (Parkinson's Disease Questionnaire-39).

Results: The leading dexterity activities participants reported as difficult and meaningful included using a touchscreen, pulling on socks, and dialing a phone. Perceived dexterity significantly correlated with self-reported ADL function (r = 0.716), QOL (r = 0.691), disease severity (r = 0.470), and dominant-hand dexterity (r = 0.432). Dexterity ability and disease severity explained 30% of perceived dexterity variance. No differences in perceived dexterity function based on dominance affectedness were found.

Conclusions: PWP encounter challenges in complex dexterity tasks that impact their independence. Before interventions focused on UL function are initiated, assessments of PWP should include inquiries about the meaningfulness of challenging dexterity activities.

背景:帕金森病患者普遍存在灵活性障碍:帕金森病(PWP)患者普遍存在灵活性障碍,但人们对上肢(UL)功能障碍对日常活动表现的影响知之甚少:目的是:(1)绘制对帕金森病患者影响最大、最有意义的灵巧活动图;(2)探讨感知灵巧功能与疾病严重程度、认知和运动UL障碍、灵巧能力、自我报告的日常生活(ADL)功能和生活质量(QOL)之间的关联;(3)研究解释感知灵巧功能的变量;以及(4)根据优势受影响程度研究感知灵巧功能的差异:共有 43 名残疾人(平均年龄 = 70.00 岁,标准差 [SD] = 6.75岁)的感知灵巧功能(36项灵巧性问卷[DextQ-36])、灵巧能力(硬币旋转任务)、疾病严重程度(改良的Hoen和Yahr量表)、自我报告的ADL功能和运动UL损伤(运动障碍协会-统一帕金森病评分量表)、认知(蒙特利尔认知评估)和QOL(帕金森病问卷-39)进行了评估:参与者认为有难度和有意义的主要灵巧活动包括使用触摸屏、穿袜子和拨电话。感知灵巧性与自我报告的ADL功能(r = 0.716)、QOL(r = 0.691)、疾病严重程度(r = 0.470)和优势手灵巧性(r = 0.432)显著相关。灵巧能力和疾病严重程度解释了30%的感知灵巧性差异。结论:残疾人在复杂灵巧动作方面面临挑战:结论:残疾人在完成复杂的灵活性任务时会遇到困难,这影响了他们的独立性。在启动以 UL 功能为重点的干预措施之前,对残疾人的评估应包括询问具有挑战性的灵巧活动是否有意义。
{"title":"Patient Perspectives on Upper-Limb Daily Function in Parkinson's Disease.","authors":"Noa Cohen, Rachel Kizony","doi":"10.1002/mdc3.14277","DOIUrl":"https://doi.org/10.1002/mdc3.14277","url":null,"abstract":"<p><strong>Background: </strong>Dexterity impairments are common among people with Parkinson's disease (PWP), yet little is understood about the effect of upper-limb (UL) dysfunction on daily activity performance.</p><p><strong>Objectives: </strong>The aims were to (1) map the dexterity activities most affected and meaningful to PWP; (2) explore the associations between perceived dexterity function and disease severity, cognitive and motor UL impairments, dexterity ability, self-reported activities of daily living (ADL) function, and quality of life (QOL); (3) investigate variables explaining perceived dexterity function; and (4) examine the differences in perceived dexterity function based on dominance affectedness.</p><p><strong>Methods: </strong>A total of 43 PWP (mean age = 70.00 years, standard deviation [SD] = 6.75) were assessed for perceived dexterity function (36-item Dexterity Questionnaire [DextQ-36]), dexterity ability (Coin Rotation Task), disease severity (modified Hoen and Yahr Scale), self-reported ADL function and motor UL impairments (Movement Disorder Society-Unified Parkinson's Disease Rating Scale), cognition (Montreal Cognitive Assessment), and QOL (Parkinson's Disease Questionnaire-39).</p><p><strong>Results: </strong>The leading dexterity activities participants reported as difficult and meaningful included using a touchscreen, pulling on socks, and dialing a phone. Perceived dexterity significantly correlated with self-reported ADL function (r = 0.716), QOL (r = 0.691), disease severity (r = 0.470), and dominant-hand dexterity (r = 0.432). Dexterity ability and disease severity explained 30% of perceived dexterity variance. No differences in perceived dexterity function based on dominance affectedness were found.</p><p><strong>Conclusions: </strong>PWP encounter challenges in complex dexterity tasks that impact their independence. Before interventions focused on UL function are initiated, assessments of PWP should include inquiries about the meaningfulness of challenging dexterity activities.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142676199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Habit Reversal Therapy and Acceptance and Commitment Therapy for Treatment of Tics in Tourette Syndrome: A Pilot Study of Effectiveness and Response Duration. 联合习惯逆转疗法和接纳与承诺疗法治疗妥瑞症抽搐症:关于疗效和反应持续时间的试点研究。
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-18 DOI: 10.1002/mdc3.14260
Jennifer Eisenhauer, Alison Buckland, Stuart Watson, Rick Stell

Background: Few studies have examined the effectiveness and duration of mindfulness-based therapies for tics in Tourette's syndrome. This study combined habit reversal therapy (HRT) with acceptance and commitment therapy (ACT).

Objectives: To evaluate the efficacy and response duration of HRT + ACT in reducing tic severity in adults with Tourette's Syndrome.

Methods: Tic severity was assessed at baseline, post-intervention, and at 6- and 12-month follow-ups using the Yale Global Tic Severity Scale (YGTSS) and video assessments. The intervention included eight weekly 1-h sessions.

Results: Mixed-effects regression showed significant reductions in tic severity post-treatment (b = -10.36, P = 0.002), maintained at 6 months (b = -8.19, P = 0.012) and 12 months (b = -8.82, P = 0.009). Video assessments confirmed these findings.

Conclusion: The HRT + ACT protocol effectively reduced tic severity, with benefits lasting 12 months. These results support further trials to compare HRT + ACT with HRT alone.

背景:很少有研究对基于正念的疗法治疗抽动秽语综合征的有效性和持续时间进行研究。本研究将习惯逆转疗法(HRT)与接受和承诺疗法(ACT)相结合:评估习惯逆转疗法+接纳与承诺疗法在降低成人妥瑞症患者抽搐严重程度方面的疗效和反应持续时间:方法: 在基线、干预后、6 个月和 12 个月的随访中,使用耶鲁全球抽搐严重程度量表(YGTSS)和视频评估对抽搐严重程度进行评估。干预包括每周八次、每次 1 小时的疗程:混合效应回归显示,治疗后抽搐严重程度明显降低(b = -10.36,P = 0.002),并在 6 个月(b = -8.19,P = 0.012)和 12 个月(b = -8.82,P = 0.009)时保持不变。视频评估证实了这些结果:HRT+ACT方案有效降低了抽搐的严重程度,其疗效可持续12个月。这些结果支持进一步进行试验,比较 HRT + ACT 与单独使用 HRT 的效果。
{"title":"Combined Habit Reversal Therapy and Acceptance and Commitment Therapy for Treatment of Tics in Tourette Syndrome: A Pilot Study of Effectiveness and Response Duration.","authors":"Jennifer Eisenhauer, Alison Buckland, Stuart Watson, Rick Stell","doi":"10.1002/mdc3.14260","DOIUrl":"https://doi.org/10.1002/mdc3.14260","url":null,"abstract":"<p><strong>Background: </strong>Few studies have examined the effectiveness and duration of mindfulness-based therapies for tics in Tourette's syndrome. This study combined habit reversal therapy (HRT) with acceptance and commitment therapy (ACT).</p><p><strong>Objectives: </strong>To evaluate the efficacy and response duration of HRT + ACT in reducing tic severity in adults with Tourette's Syndrome.</p><p><strong>Methods: </strong>Tic severity was assessed at baseline, post-intervention, and at 6- and 12-month follow-ups using the Yale Global Tic Severity Scale (YGTSS) and video assessments. The intervention included eight weekly 1-h sessions.</p><p><strong>Results: </strong>Mixed-effects regression showed significant reductions in tic severity post-treatment (b = -10.36, P = 0.002), maintained at 6 months (b = -8.19, P = 0.012) and 12 months (b = -8.82, P = 0.009). Video assessments confirmed these findings.</p><p><strong>Conclusion: </strong>The HRT + ACT protocol effectively reduced tic severity, with benefits lasting 12 months. These results support further trials to compare HRT + ACT with HRT alone.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progression of Dopaminergic Therapy Changes in Parkinson's Disease in Asian and Native Hawaiian and Pacific Islander Populations. 多巴胺能疗法在亚裔、夏威夷原住民和太平洋岛民帕金森病中的进展变化。
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-18 DOI: 10.1002/mdc3.14280
Kirra Borrello, Shay Nakahira, Paul Fontana, Darrel Guittu, Chanel Hunter, Anson Lee, Julia Jahansooz, Edward Weldon, Meliza Roman, Hyeong Jun Ahn, Enrique Carrazana, Kore Liow
{"title":"Progression of Dopaminergic Therapy Changes in Parkinson's Disease in Asian and Native Hawaiian and Pacific Islander Populations.","authors":"Kirra Borrello, Shay Nakahira, Paul Fontana, Darrel Guittu, Chanel Hunter, Anson Lee, Julia Jahansooz, Edward Weldon, Meliza Roman, Hyeong Jun Ahn, Enrique Carrazana, Kore Liow","doi":"10.1002/mdc3.14280","DOIUrl":"https://doi.org/10.1002/mdc3.14280","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can We Better Predict the Timing for Medication Initiation in Early PD? 我们能否更好地预测早期帕金森病的用药时机?
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-18 DOI: 10.1002/mdc3.14279
Carlo Colosimo, Luca Marsili
{"title":"Can We Better Predict the Timing for Medication Initiation in Early PD?","authors":"Carlo Colosimo, Luca Marsili","doi":"10.1002/mdc3.14279","DOIUrl":"https://doi.org/10.1002/mdc3.14279","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population-based Study. 一项基于人口的研究中有关帕金森病风险披露的偏好。
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-18 DOI: 10.1002/mdc3.14264
Philipp Mahlknecht, Simon Leiter, Corinne Horlings, Katarína Schwarzová, Iris Egner, Heike Stockner, Kathrin Marini, Christoph Theyer, Laura Zamarian, Atbin Djamshidian, Klaus Seppi, Fernanda Farfan, Alicia Garrido, Soumyabrata Ghosh, Rejko Krüger, Deborah McIntyre, Brit Mollenhauer, Alastair Noyce, Claire Pauly, Daniel F Pilco-Janeta, Kavita Rege, Venkata P Satagopam, Sebastian Schade, Cristina Simonet, Claudia Trenkwalder, Werner Poewe

Background: Preferences for risk disclosure in population-based studies assessing Parkinson's disease (PD) risk have not been assessed so far.

Objectives: To examine preferences for risk disclosure in a subset of the European Healthy Brain Aging (HeBA) multicenter study.

Methods: After a remote PD risk assessment, a structured pilot-questionnaire on risk disclosure was first presented to participants (≥50 years, without neurodegenerative diseases) during in-person visits at the Innsbruck study site.

Results: From the included 81 participants (63% females, median age 65 years), 79% expressed an unconditional desire to be informed about their PD risk. Confronted with a hypothetical scenario of a positive, specific PD test, most would try to live a healthier lifestyle. Regarding future placebo-controlled disease-modification trials, 66% stated they would probably or definitely participate.

Conclusions: This pilot-study shows an open-minded view of participants towards disclosure of risk for future PD and a proactive attitude regarding dealing with one's risk.

背景:在以人群为基础的帕金森病(PD)风险评估研究中,迄今为止尚未对风险披露的偏好进行评估:在欧洲健康脑老龄化(HeBA)多中心研究的一个子集中考察风险披露的偏好:方法:在对脑退化症风险进行远程评估后,首先在因斯布鲁克研究基地对参与者(年龄≥50岁,无神经退行性疾病)进行面对面访问,向他们发放结构化的风险披露试点问卷:在81名参与者(63%为女性,中位年龄为65岁)中,79%的人表示无条件希望了解自己的帕金森病风险。面对假想的阳性、特定的帕金森病检测结果,大多数人都会尝试过更健康的生活方式。关于未来的安慰剂对照疾病调整试验,66%的人表示他们可能会或一定会参加:这项试点研究表明,参与者对披露未来帕金森病风险持开放态度,并对应对自身风险持积极态度。
{"title":"Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population-based Study.","authors":"Philipp Mahlknecht, Simon Leiter, Corinne Horlings, Katarína Schwarzová, Iris Egner, Heike Stockner, Kathrin Marini, Christoph Theyer, Laura Zamarian, Atbin Djamshidian, Klaus Seppi, Fernanda Farfan, Alicia Garrido, Soumyabrata Ghosh, Rejko Krüger, Deborah McIntyre, Brit Mollenhauer, Alastair Noyce, Claire Pauly, Daniel F Pilco-Janeta, Kavita Rege, Venkata P Satagopam, Sebastian Schade, Cristina Simonet, Claudia Trenkwalder, Werner Poewe","doi":"10.1002/mdc3.14264","DOIUrl":"10.1002/mdc3.14264","url":null,"abstract":"<p><strong>Background: </strong>Preferences for risk disclosure in population-based studies assessing Parkinson's disease (PD) risk have not been assessed so far.</p><p><strong>Objectives: </strong>To examine preferences for risk disclosure in a subset of the European Healthy Brain Aging (HeBA) multicenter study.</p><p><strong>Methods: </strong>After a remote PD risk assessment, a structured pilot-questionnaire on risk disclosure was first presented to participants (≥50 years, without neurodegenerative diseases) during in-person visits at the Innsbruck study site.</p><p><strong>Results: </strong>From the included 81 participants (63% females, median age 65 years), 79% expressed an unconditional desire to be informed about their PD risk. Confronted with a hypothetical scenario of a positive, specific PD test, most would try to live a healthier lifestyle. Regarding future placebo-controlled disease-modification trials, 66% stated they would probably or definitely participate.</p><p><strong>Conclusions: </strong>This pilot-study shows an open-minded view of participants towards disclosure of risk for future PD and a proactive attitude regarding dealing with one's risk.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differentiating Essential and Dystonic Head Tremor: Exploring Arm Position Effects. 区分强直性震颤和肌张力障碍性震颤:探索手臂位置的影响
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-15 DOI: 10.1002/mdc3.14269
Tereza Hubená, Petr Hollý, Aneta Pavlíková, Olga Ulmanová, Jan Rusz, Radim Krupička, Evžen Růžička

Background: Head tremor poses diagnostic problems, especially when present as an isolated or predominant symptom.

Objectives: To assess how maneuvers activating upper limb postural tremor can help differentiate head tremor in essential tremor (ET) from dystonic tremor (DT) in cervical dystonia.

Methods: 48 patients with head tremor (25 ET, 23 DT), underwent clinical examination and accelerometric evaluation of head and upper limb tremor during routine tremor-inducing tasks.

Results: While accelerometric power and clinical scores of head tremor did not significantly differ between patient groups, task-induced variations revealed distinctions. ET patients exhibited increased head tremor power and clinical scores during forward outstretched and lateral wing-beating arm positions, unlike DT patients. Coherence between head and upper limb tremor remained consistent. Tremor stability index showed no significant differences.

Conclusions: Task-induced changes in head tremor could aid in distinguishing between ET and DT. Further research is needed to refine diagnostic approaches for head tremor.

背景:头部震颤会给诊断带来困难,尤其是在作为孤立或主要症状出现时:方法:48 位头部震颤患者(25 位 ET,23 位 DT)接受了临床检查和常规震颤诱发任务中头部和上肢震颤的加速度评估:虽然加速度测量功率和头部震颤的临床评分在不同患者组之间没有显著差异,但任务诱发的变化却显示出了区别。与 DT 患者不同的是,ET 患者在前伸和侧翼拍打手臂姿势时,头部震颤力和临床评分均有所增加。头部震颤和上肢震颤之间的一致性保持一致。震颤稳定性指数无明显差异:任务引起的头部震颤变化有助于区分 ET 和 DT。需要进一步研究以完善头部震颤的诊断方法。
{"title":"Differentiating Essential and Dystonic Head Tremor: Exploring Arm Position Effects.","authors":"Tereza Hubená, Petr Hollý, Aneta Pavlíková, Olga Ulmanová, Jan Rusz, Radim Krupička, Evžen Růžička","doi":"10.1002/mdc3.14269","DOIUrl":"https://doi.org/10.1002/mdc3.14269","url":null,"abstract":"<p><strong>Background: </strong>Head tremor poses diagnostic problems, especially when present as an isolated or predominant symptom.</p><p><strong>Objectives: </strong>To assess how maneuvers activating upper limb postural tremor can help differentiate head tremor in essential tremor (ET) from dystonic tremor (DT) in cervical dystonia.</p><p><strong>Methods: </strong>48 patients with head tremor (25 ET, 23 DT), underwent clinical examination and accelerometric evaluation of head and upper limb tremor during routine tremor-inducing tasks.</p><p><strong>Results: </strong>While accelerometric power and clinical scores of head tremor did not significantly differ between patient groups, task-induced variations revealed distinctions. ET patients exhibited increased head tremor power and clinical scores during forward outstretched and lateral wing-beating arm positions, unlike DT patients. Coherence between head and upper limb tremor remained consistent. Tremor stability index showed no significant differences.</p><p><strong>Conclusions: </strong>Task-induced changes in head tremor could aid in distinguishing between ET and DT. Further research is needed to refine diagnostic approaches for head tremor.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142639381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Impact of Parkinson's Disease on Driving: A Population-Based Survey. 探索帕金森病对驾驶的影响:基于人口的调查。
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-15 DOI: 10.1002/mdc3.14275
Marjan J Meinders, Bart R Maas, Bastiaan R Bloem, Hans van Geluk, Sirwan K L Darweesh

Background: Persons with Parkinson's disease (PD) experience progressive motor and non-motor symptoms which may influence their ability to drive a car. This is experienced as a massive challenge by many affected individuals, for whom being able to drive a car is vital to maintain functional independence.

Objectives: We assessed how the diagnosis of PD affected the possession of a driving license, how people with PD had adapted their driving style, and to what extent they had communicated about their driving ability with their healthcare professionals. We also evaluated their knowledge on insurance- and Driver and Vehicle Licensing Agency (DVLA)-related implications.

Method: A cross-sectional 10-item survey was completed by 540 participants of a population-based cohort of persons with PD in the Netherlands (PRIME-NL study).

Results: Participants had a mean age of 70 years and disease duration of 7.3 years. 84% possessed a valid driving license. Of those who gave up their license, this was done mostly (78%) on a voluntarily basis. Forty percent of those with a driving license adjusted their driving style. Over 50% of respondents had not discussed the impact of PD on their driving ability with their healthcare professionals. Although not compulsory by Dutch law, 52% of the respondents had informed the DVLA about their diagnosis.

Conclusion: This study highlights the need for information and support from healthcare professionals to proactively address driving in their clinical practice. This will help persons with PD in their efforts to maintain their driving license for as long as possible.

背景:帕金森病(PD)患者会出现进行性运动和非运动症状,这可能会影响他们驾驶汽车的能力。这对许多患者来说都是一个巨大的挑战,因为对于他们来说,能够驾驶汽车对于保持功能独立至关重要:我们评估了帕金森氏症的诊断对持有驾驶执照的影响、帕金森氏症患者如何调整自己的驾驶方式,以及他们在多大程度上与医疗保健专业人员就自己的驾驶能力进行了沟通。我们还评估了他们对保险以及驾驶员和车辆牌照局(DVLA)相关影响的了解程度:方法:我们对荷兰基于人群的帕金森病患者队列(PRIME-NL 研究)中的 540 名参与者进行了一项 10 个项目的横向调查:参与者的平均年龄为 70 岁,病程为 7.3 年。84%的人拥有有效驾驶执照。在放弃驾照的人中,大部分(78%)是自愿放弃的。有驾驶执照的受访者中有 40% 调整了驾驶方式。超过 50% 的受访者没有与他们的医疗保健专业人员讨论过帕金森病对其驾驶能力的影响。虽然荷兰法律没有强制规定,但 52% 的受访者已将其诊断结果告知 DVLA:本研究强调,医疗保健专业人员需要提供信息和支持,以便在临床实践中积极主动地解决驾驶问题。这将有助于帕金森病患者尽可能长时间地保持驾驶执照。
{"title":"Exploring the Impact of Parkinson's Disease on Driving: A Population-Based Survey.","authors":"Marjan J Meinders, Bart R Maas, Bastiaan R Bloem, Hans van Geluk, Sirwan K L Darweesh","doi":"10.1002/mdc3.14275","DOIUrl":"https://doi.org/10.1002/mdc3.14275","url":null,"abstract":"<p><strong>Background: </strong>Persons with Parkinson's disease (PD) experience progressive motor and non-motor symptoms which may influence their ability to drive a car. This is experienced as a massive challenge by many affected individuals, for whom being able to drive a car is vital to maintain functional independence.</p><p><strong>Objectives: </strong>We assessed how the diagnosis of PD affected the possession of a driving license, how people with PD had adapted their driving style, and to what extent they had communicated about their driving ability with their healthcare professionals. We also evaluated their knowledge on insurance- and Driver and Vehicle Licensing Agency (DVLA)-related implications.</p><p><strong>Method: </strong>A cross-sectional 10-item survey was completed by 540 participants of a population-based cohort of persons with PD in the Netherlands (PRIME-NL study).</p><p><strong>Results: </strong>Participants had a mean age of 70 years and disease duration of 7.3 years. 84% possessed a valid driving license. Of those who gave up their license, this was done mostly (78%) on a voluntarily basis. Forty percent of those with a driving license adjusted their driving style. Over 50% of respondents had not discussed the impact of PD on their driving ability with their healthcare professionals. Although not compulsory by Dutch law, 52% of the respondents had informed the DVLA about their diagnosis.</p><p><strong>Conclusion: </strong>This study highlights the need for information and support from healthcare professionals to proactively address driving in their clinical practice. This will help persons with PD in their efforts to maintain their driving license for as long as possible.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142639383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opsoclonus in Alternating Hemiplegia of Childhood Secondary to ATP1A3 p.Gly803Arg. 继发于 ATP1A3 p.Gly803Arg 的儿童交替性偏瘫中的肌阵挛。
IF 2.6 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-11-14 DOI: 10.1002/mdc3.14274
Alyssa D Runco, Jesse M Levine, Cristina Trandafir, Rod Foroozan, Mered Parnes, Daniel G Calame
{"title":"Opsoclonus in Alternating Hemiplegia of Childhood Secondary to ATP1A3 p.Gly803Arg.","authors":"Alyssa D Runco, Jesse M Levine, Cristina Trandafir, Rod Foroozan, Mered Parnes, Daniel G Calame","doi":"10.1002/mdc3.14274","DOIUrl":"https://doi.org/10.1002/mdc3.14274","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142624311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Movement Disorders Clinical Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1